Researchers update clinical practice guidelines for how to prevent and monitor hepatitis B virus reactivation.

Having peers facilitate virtual visits may lead to many more patients with hepatitis C receiving treatment and clearing the ...

The (AGA) has unveiled an updated clinical practice guideline in Gastroenterology addressing the prevention and management of hepatitis B virus reactivation (HBVr) in patients on immunosuppressive ...

The US Food and Drug Administration (FDA) has granted breakthrough therapy designation to Bluejay Therapeutics’ fully human ...

The use of injected drugs is the most common way that people contract hepatitis C in the United States and Europe. When you inject drugs, the needle breaks the surface of your skin and comes into ...

The FDA announced the changes in a “ prevention strategy ” to keep fresh and frozen berries from being contaminated with ...

Opens in a new tab or window The American Gastroenterology Association (AGA) issued a new clinical guideline recommending antiviral drugs for patients at high risk for hepatitis B reactivation.

Patients with HIV and hepatitis B coinfection are at an increased risk for hepatitis D, which is associated with an increased ...

In severe cases, the illness can lead to unconsciousness. Hepatitis can be caused not only by viruses and drug use but also by conditions in which the body’s immune system destroys liver cells.

The Food and Drug Administration (FDA) has granted Breakthrough Therapy designation to brelovitug (BJT-778) for the treatment of chronic hepatitis delta (CHD).